The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMYXR.L Regulatory News (MYXR)

  • There is currently no data for MYXR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consolidation of Stock Lines

21 Sep 2017 07:00

RNS Number : 3607R
MyCelx Technologies Corporation
21 September 2017
 

 

21 September 2017

MYCELX TECHNOLOGIES CORPORATION

("MYCELX" or the "Company")

Consolidation of Stock Lines

 

MYCELX Technologies Corporation (AIM: MYX), the clean water technology company providing patented solutions for the Oil and Gas market and commercial industrial markets worldwide, announces that it is simplifying the shareholding structure of the Company by consolidating its two existing lines of stock under the one unrestricted line of stock.

Trading in the Company's restricted line of stock with the ticker MYXR (identified under ISIN USU624551078 and SEDOL B56S0J1) (the "Restricted Line") will cease at 8.00 a.m. on 29 September 2017 and all common shares of $0.025 each ("Common Shares") currently trading on the Restricted Line will from then on continue to trade on the unrestricted line of stock with the ticker MYX (identified under ISIN US62847T2024 and SEDOL B8NZQP4) (the "Unrestricted Line").

The Depositary Interest Facility, operated with Capita IRG Trustees Limited, in relation to the Restricted Line will be terminated with effect from 5.00 p.m. on 28 September 2017.

The Company has applied to the London Stock Exchange for all 797,695 Common Shares currently traded on the Restricted Line to be transferred to the Unrestricted Line at 08.00 a.m. on 29 September 2017.

New share certificates for the Unrestricted Line will be sent to certificated shareholders previously holding the Restricted Line by 13 October 2017.

Total Voting Rights

The Company's issued share capital consists of 18,770,117 Common Shares with no Common Shares held in treasury. Therefore, the total number of voting rights in the Company is 18,770,117 which may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

From 29 September 2017, all of the 18,770,117 Common Shares will be admitted to trading on the Unrestricted Line.

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - NOMAD and Broker

Andrew Craig

Richard Salmond

 

 

Tel: +44 20 7894 7000

Celicourt Communications

Mark Antelme

Jimmy Lea

 

Tel: +44 20 7520 9266

 

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CARBIGDCLUDBGRG
Date   Source Headline
14th Mar 20234:50 pmRNSClosure of Restricted Stock Line
13th Feb 20237:00 amRNSOperational Update
31st Jan 20237:00 amRNSTrading Update
8th Dec 20227:00 amRNSTrading Update
27th Sep 20227:00 amRNSHalf Year Results Statement
15th Sep 20227:00 amRNSTrading Update
6th Sep 20222:30 pmRNSHolding(s) in Company
30th Aug 20227:00 amRNSNew Project Awards and Operations Update
13th Jul 20223:32 pmRNSResult of Annual Meeting
13th Jun 20227:00 amRNS2021 Annual Report & Notice of 2022 Annual Meeting
17th May 20227:00 amRNSFinal Results for Year Ending 31 December 2021
3rd May 20227:00 amRNSDirector/PDMR Shareholding
3rd May 20227:00 amRNSChange of Main Office Address
23rd Mar 20229:17 amRNSTR1
21st Mar 20225:56 pmRNSBroker Option
9th Mar 20207:00 amRNSClosure of Restricted Stock Line
5th Mar 20207:00 amRNSTrading Update
13th Dec 201910:25 amRNSBlock listing Interim Review
4th Nov 20197:00 amRNSTrading Update
16th Sep 20197:00 amRNSHalf Year Results Statement
20th Aug 201912:42 pmRNSHolding(s) in Company
16th Aug 20193:02 pmRNSDirector Shareholding
29th Jul 20197:00 amRNSDirectorate Changes
26th Jul 20197:00 amRNSAppointment of Nominated Adviser & Broker
22nd Jul 20191:34 pmRNSHolding(s) in Company
10th Jul 201912:57 pmRNSResult of Annual Meeting
14th Jun 20197:00 amRNSTrading Update
11th Jun 20197:00 amRNSBlock listing Interim Review
6th Jun 20197:00 amRNSIssue of Equity
31st May 20191:57 pmRNSAnnual Financial Report
13th May 20197:00 amRNSFinal Results for the year ending 31 December 2018
28th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSHolding(s) in Company
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.